A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations
| Image |  |
|---|---|
| Description | scientific article published on 11 February 2019 |
| Author/s |
author: Martin H Voss Josep Tabernero Caturla |
| Publication date | February 11, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |